Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Bicycle, Novartis ink oncology deal worth up to $1.7B
Ready or not, here comes med device cybersecurity legislation
Biotech heads towards big catalysts
*please scroll down for all the latest news*
